Viewing nowTerbinafine Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

MFDS item code 200308832 · Notified 2003.07.14
Treatment of onychomycosis, dermatophytosis (tinea pedis, tinea corporis, etc.), and tinea capitis
This medication is used to treat fungal infections of the skin and nails in both adults and children. In adults, it is effective against dermatophyte infections like athlete's foot, tinea corporis, tinea cruris, and nail fungus. In children, it is used to treat tinea capitis. This medication improves fungal infections of the skin and nails.
Administer terbinafine at a dose of 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. Infections of the fingernails or relatively small toenails, or in younger patients, may require treatment for less than 3 months. Usually, 3 months is sufficient to treat toenail infections, although treatment may take 6 months or longer in some patients. Treatment may need to be prolonged in patients with slow nail growth. 3. Patients with renal impairment Reduce the daily dose by 1/2 in patients with creatinine clearance less than 50 mL/min.
Administer to children 2 years of age and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment must be given regularly for the appropriate prescribed duration. 1) Body weight less than 20 kg (under 5 years): Administer 62.5 mg once daily. Because experience with administration is limited, decide whether to administer after considering the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. 3) Body weight greater than 40 kg (over 12 years): Administer 250 mg once daily.
This medication is not recommended for patients with chronic or active liver disease. Before taking this medication, it is essential to check for the presence of liver disease, and all patients should undergo regular liver function tests before and during treatment. Symptoms of liver dysfunction, such as persistent nausea, loss of appetite, fatigue, vomiting, pain in the upper right abdomen, jaundice, dark urine, and pale stools, must be reported to a doctor immediately. This medication can cause liver failure, so it should be discontinued promptly if liver damage is suspected. This medication should not be administered to patients with certain blood disorders, severe renal failure, breastfeeding mothers, and infants under 2 years of age. Patients with a history of hypersensitivity to this medication or lactose intolerance should also avoid its use. Patients with impaired kidney function, the elderly, children weighing less than 20 kg, and those with psoriasis or systemic lupus erythematosus should use this medication cautiously. Severe skin reactions may rarely occur, so if any skin rash or abnormal symptoms develop, medication should be stopped immediately. This medication may cause various side effects affecting the liver, blood, skin, musculoskeletal system, gastrointestinal tract, and nervous system; therefore, regular testing is necessary, and healthcare providers should be consulted immediately for any abnormal symptoms. This medication can impair the ability to drive or operate machinery, so caution should be exercised in case of dizziness or drowsiness. This medication may interact with other drugs; therefore, if you are taking other medications, you must inform your doctor or pharmacist, and dose adjustments may be necessary. Women who are pregnant or may become pregnant should use this medication cautiously, and breastfeeding mothers should discontinue nursing. In cases of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may occur, requiring immediate medical attention. This medication should be kept out of reach of children and stored in a cool, dry place, away from direct sunlight.
Liver and gallbladder dysfunction, hepatitis, bile duct obstruction, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, lethargy, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesicular dermatitis, psoriasiform rash, psoriasis exacerbation, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, paresthesia, sensory loss, decreased attention, insomnia, elevated BUN, polyuria, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated serum total cholesterol, elevated triglyceride levels, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, visual impairment, hearing loss, auditory impairment, vasculitis, permanent anosmia, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in an airtight container that allows for good ventilation, maintaining a storage temperature between 1 to 30 degrees Celsius. Proper storage preserves the efficacy of the medication and prevents degradation.
White to off-white round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.